KPTI filings
Corporate insider profile
Stuart Poulton Filing Activity
Latest reported as EVP, Chief Development Officer of Karyopharm Therapeutics Inc. (KPTI).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$3,828.50
- Latest transaction
- May 14, 2026
Affiliated corporations
Reported company relationships
Transaction history
